SE393106B - Forfarande for framstellning av sulfonamider med kerldilaterande verken - Google Patents

Forfarande for framstellning av sulfonamider med kerldilaterande verken

Info

Publication number
SE393106B
SE393106B SE7204239A SE423972A SE393106B SE 393106 B SE393106 B SE 393106B SE 7204239 A SE7204239 A SE 7204239A SE 423972 A SE423972 A SE 423972A SE 393106 B SE393106 B SE 393106B
Authority
SE
Sweden
Prior art keywords
sulphonamides
works
procedure
preparation
vessel dilating
Prior art date
Application number
SE7204239A
Other languages
English (en)
Swedish (sv)
Inventor
A Mentrup
K Schromm
E-O Renth
W Traunecker
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of SE393106B publication Critical patent/SE393106B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
SE7204239A 1971-04-01 1972-03-30 Forfarande for framstellning av sulfonamider med kerldilaterande verken SE393106B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2115926A DE2115926C3 (de) 1971-04-01 1971-04-01 1 -(4-Hydroxy-3-dimethylaminosuIfamidophenyI)-2-aminoäthanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Mittel

Publications (1)

Publication Number Publication Date
SE393106B true SE393106B (sv) 1977-05-02

Family

ID=5803592

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7204239A SE393106B (sv) 1971-04-01 1972-03-30 Forfarande for framstellning av sulfonamider med kerldilaterande verken

Country Status (20)

Country Link
US (1) US4038314A (es)
JP (3) JPS5735193B1 (es)
AR (6) AR204905A1 (es)
AT (7) AT327174B (es)
AU (1) AU470838B2 (es)
BE (1) BE781542A (es)
CH (6) CH572905A5 (es)
DE (1) DE2115926C3 (es)
DK (1) DK140836B (es)
ES (4) ES401332A1 (es)
FI (1) FI58325C (es)
FR (1) FR2132372B1 (es)
GB (1) GB1381184A (es)
IE (1) IE36240B1 (es)
IL (1) IL39110A (es)
NL (1) NL170850C (es)
NO (1) NO135247C (es)
PH (1) PH14121A (es)
SE (1) SE393106B (es)
ZA (1) ZA722177B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435721A (en) * 1972-05-18 1976-05-12 Lilly Industries Ltd Benzoxazole derivatives
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
US4558156A (en) * 1980-02-08 1985-12-10 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl-substituted phenethylamine derivatives
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
DE3220598A1 (de) * 1982-06-01 1983-12-01 Boehringer Ingelheim KG, 6507 Ingelheim Lipolytische zusammensetzungen und mittel zur behandlung der fettsucht
GB8322178D0 (en) * 1983-08-17 1983-09-21 Sterwin Ag Preparing aerosol compositions
GB8502892D0 (en) * 1985-02-05 1985-03-06 Sterwin Ag Aerosol composition
JPH0228141A (ja) * 1987-11-13 1990-01-30 Glaxo Group Ltd フェネタノールアミン誘導体
US20040127733A1 (en) 2002-10-31 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg New beta-agonists, processes for preparing them and their use as pharmaceutical compositions
DE10251170A1 (de) * 2002-10-31 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102004021779A1 (de) 2004-04-30 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE102005052127A1 (de) 2005-10-28 2007-05-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue indol-haltige Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
US7718822B2 (en) 2007-08-28 2010-05-18 Sepracor Inc. Carbamate Stereoisomer
CN109535007A (zh) * 2018-11-07 2019-03-29 万华化学集团股份有限公司 一种二氨基二环己基甲烷同分异构体分离方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3804834A (en) * 1967-10-16 1974-04-16 Boehringer Sohn Ingelheim 1-(2',3',4'-trisubstituted-phenyl)-2-amino-alkanols-(1)and salts thereof
US3701808A (en) * 1967-12-21 1972-10-31 Allen & Hanburys Ltd Phenylethanolamines
US3574741A (en) * 1969-04-14 1971-04-13 Mead Johnson & Co Sulfonamidophenalkylamines
US3711545A (en) * 1971-02-23 1973-01-16 Smith Kline French Lab Alpha-aminoalkyl-4-hydroxy-3-sulfamoylaminobenzyl alcohols
BE794414A (fr) * 1972-01-25 1973-07-23 Sandoz Sa Nouveaux amino-alcools, leur preparation et leur application comme medicament

Also Published As

Publication number Publication date
CH580069A5 (es) 1976-09-30
AR210055A1 (es) 1977-06-30
NL170850C (nl) 1983-01-03
ES419934A1 (es) 1976-05-01
NO135247B (es) 1976-11-29
NL7204316A (es) 1972-10-03
AR199809A1 (es) 1974-09-30
AT327173B (de) 1976-01-26
AT321888B (de) 1975-04-25
JPS5718662A (en) 1982-01-30
IL39110A (en) 1975-02-10
CH590219A5 (es) 1977-07-29
PH14121A (en) 1981-02-26
GB1381184A (en) 1975-01-22
AT327174B (de) 1976-01-26
FI58325C (fi) 1981-01-12
AR200116A1 (es) 1974-10-24
DE2115926A1 (de) 1972-10-12
AR200002A1 (es) 1974-10-15
JPS5718660A (en) 1982-01-30
CH587237A5 (es) 1977-04-29
CH580068A5 (es) 1976-09-30
DK140836C (es) 1980-04-21
ATA915174A (de) 1975-04-15
JPS5929190B2 (ja) 1984-07-18
ES419935A1 (es) 1976-05-01
AT321889B (de) 1975-04-25
AR204905A1 (es) 1976-03-19
CH572905A5 (en) 1976-02-27
FR2132372B1 (es) 1975-06-20
ATA284472A (de) 1975-03-15
JPS5929191B2 (ja) 1984-07-18
FI58325B (fi) 1980-09-30
DE2115926C3 (de) 1978-05-03
ZA722177B (en) 1973-12-19
NO135247C (es) 1977-03-09
ES401332A1 (es) 1975-02-16
AU4059272A (en) 1973-10-04
ES419936A1 (es) 1976-05-01
ATA915074A (de) 1975-04-15
DK140836B (da) 1979-11-26
IE36240B1 (en) 1976-09-15
IE36240L (en) 1972-10-01
AT326628B (de) 1975-12-29
AU470838B2 (en) 1973-10-04
AR209268A1 (es) 1977-04-15
DE2115926B2 (de) 1977-09-15
NL170850B (nl) 1982-08-02
FR2132372A1 (es) 1972-11-17
AT320613B (de) 1975-02-25
US4038314A (en) 1977-07-26
JPS5735193B1 (es) 1982-07-27
CH587236A5 (es) 1977-04-29
IL39110A0 (en) 1972-05-30
BE781542A (fr) 1972-10-02

Similar Documents

Publication Publication Date Title
SE392269B (sv) Forfarande for framstellning av vissa indanyloxitetrazoler
SE398877B (sv) Forfarande for framstellning av 14-hydroxi-morfinanderivat
SE411755B (sv) Forfarande for framstellning av n-substituerade 1-aminometylindaner
SE393106B (sv) Forfarande for framstellning av sulfonamider med kerldilaterande verken
SE400292B (sv) Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat
SE390633B (sv) Forfarande for framstellning av ethambutol
SE417200B (sv) Forfarande for framstellning av 2-nitro-5-imidazolaldehydderivat
SE397090B (sv) Forfarande for framstellning av hydroxipyrimidiner
SE405478B (sv) Forfarande for framstellning av alfa-sulfoacylcefalosporiner
SE384686B (sv) Forfarande for framstellning av linkomycinderivat
SE408177B (sv) Forfarande for framstellning av 4-hydroximetyl-1-ftalazonderivat
SE380815B (sv) Forfarande for framstellning av transparenta sampolyamider
SE387936B (sv) Forfarande for framstellning av substituerade metoxiaminer
SE394677B (sv) Forfarande for framstellning av 4-hydroxi-2h-1-bensotiopyran-3-karboxanilid-1,1-dioxider
SE382985B (sv) Forfarande for framstellning av oxazoler
SE380520B (sv) Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin
SE384210B (sv) Forfarande for framstellning av nya nitrosokarbamidderivat
SE409866B (sv) Forfarande for framstellning av adenosinderivat
SE392902B (sv) Forfarande for framstellning av fenylimidazolidinoner
SE386897B (sv) Forfarande for framstellning av n-acyl-(piperazinoetyl)-pyrazoler
SE405730B (sv) Forfarande for framstellning av kinazolinderivat
SE397350B (sv) Forfarande for framstellning av tieno-diazepinderivat
AR192654A1 (es) Procedimiento de preparacion de nuevos dibencilfenoles halogenados
SE407061B (sv) Forfarande for framstellning av bensylpyrimidiner
SE387948B (sv) Forfarande for framstellning av tiofen